Is the fertility treatment itself a risk factor for early pregnancy loss?

Current Opinion in Obstetrics and Gynecology

Volumn 26, Issue 3, 2014, Pages 174-180

  Torrealday, Saioa ^a  

^a WOMACK ARMY MEDICAL CENTER   (United States)

Author keywords

assisted reproductive technology; early pregnancy loss; fertility treatment; spontaneous abortion

Indexed keywords

AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

ANEUPLOIDY; CHROMOSOME ABERRATION; CONFOUNDING VARIABLE; DNA FRAGMENTATION; EMOTIONAL STRESS; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GRIEF; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; NONHUMAN; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PARTHENOGENESIS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REPRODUCTION; REVIEW; SEX CHROMOSOME ABERRATION; SPERMATOZOON DENSITY; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; ADULT; AGING; CONGENITAL DISORDER; EMBRYO TRANSFER; FAMILY SIZE; FEMALE; FEMALE INFERTILITY; GENETIC COUNSELING; MATERNAL AGE; MIDDLE AGED; PREGNANCY; RISK FACTOR;

ABORTION, SPONTANEOUS; ADULT; AGING; CONGENITAL ABNORMALITIES; FAMILY CHARACTERISTICS; FEMALE; GENETIC COUNSELING; HUMANS; INFERTILITY, FEMALE; MATERNAL AGE; MIDDLE AGED; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS; SINGLE EMBRYO TRANSFER; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84900436712     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000064     Document Type: Review

References (58)

1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978; 2:366.
2. Van Voorhis B. Outcomes from assisted reproductive technology. Obstet Gynecol 2006; 107:183-200.
3. Speroff L, Fritz MA. Neuroendocrinology. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 1192-1195.
4. Steer C, Campbell S, Davies M, et al. Spontaneous abortion rates after natural and assisted conceptions. Br Med J (Clin Res Ed) 1989; 299:1317-1318.
5. Simpson JL, Bombard AT. Chromosomal abnormalities in spontaneous abortion: frequency, pathology and genetic counseling. In: Edmonds K, Bennett MJ, editors. Spontaneous abortion. London: Blackwell; 1987. pp. 51-76.
6. Schieve LA, Tatham L, Peterson HB, et al. Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol 2003; 101:959-967.
7. Cramer DW, Wise LA. The epidemiology of recurrent pregnancy loss. Semin Reprod Med 2000; 18:331-339.
8. Hassold TJ. A cytogenetic study of repeated spontaneous abortions. Am J Hum Genet 1980; 32:1317-1318.
9. Guerneri S, Bettio D, Simoni G, et al. Prevalence and distribution of chromosome abnormalities in a sample of first trimester internal abortions. Hum Reprod 1987; 2:735-739.
10. Nagaishi M, Yamamoto T, Iinuma K, et al. Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan. J Obstet Gynaecol Res 2004; 30:237-241.
11. De la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod 2002; 77:357-362.
12. Kroon B, Harrison K, Martin N, et al. Miscarriage karyotype and its relationship with maternal body mass index, age, and mode of conception. Fertil Steril 2011; 95:1827-1829.
13. Nybo Anderson AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320:1708-1712.
14. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89:505-522.
15. Garcia J, Jones GS, Wentz AC. The use of clomiphene citrate. Fertil Steril 1977; 28:707-717.
16. Goldfarb AF, Morales A, Rakoff AE, Protos P. Critical review of 160 clomiphene-related pregnancies. Obstet Gynecol 1968; 31:342-345.
17. Roland M. Problems of ovulation induction with clomiphene citrate with report of a case of ovarian hyperstimulation. Obstet Gynecol 1970; 35:55-62.
18. Boue JG, Boue A. Increased frequency of chromosomal anomalies in abortions after induced ovulation. Lancet 1973; 1:679-680.
19. Laufer N, Pratt BM, DeCherney AH, et al. The in vivo and in vitro effects of clomiphene citrate on ovulation, fertilization and development of cultured mouse oocytes. Am J Obstet 1983; 147:633-639.
20. Van Hall EV, Mastboom JL. Luteal phase insufficiency in patients treated with clomiphene. Am J Obstet Gynecol 1969; 103:165-171.
21. Dickey RP, Olar TT, Taylor SN, et al. Relationship of biochemical pregnancy to preovulatory endometrial thickness and pattern in ovulation induction patients. Hum Reprod 1993; 8:327-330.
22. Bonhoff AJ, Naether OGJ, Johannisson E. Effects of clomiphene citrate stimulation on endometrial structure in infertile women. Hum Reprod 1996; 11:844-849.
23. The Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril 2013; 100:341-348.
24. Imani B, Eijkemans MJC, te Velde ER, et al. A nomogram to predict the probability of live birth after clomphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 2002; 77:91-97.
25. Dickey RP, Taylor SN, Curole DN, et al. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996; 11:2623-2628.
26. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrazole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009; 92:849-852.
27. Edgar DH, Whalley KM, Mills JA. Effects of high-dose and multiple-dose gonadotropin stimulation on mouse oocyte quality as assessed by preimplantation development following in vitro fertilization. J In Vitro Fert Embryo Transf 1987; 4:273-276.
28. Sato F, Marres RP. The effect of pregnant mare serum gonadotropins on mouse embryos fertilized in vivo or in vitro. J In Vitro Fert Embryo Transf 1986; 3:353-357.
29. Elbling L, Colot M. Abnormal development and transport and increased sisterchromatid exchange in preimplantation embryos following supraovulation in mice. Mutat Res 1985; 147:189-195.
30. Massie JAM, Shahine LK, Milki AA, et al. Ovarian stimulation and the risk of aneuploidy conceptions. Fertil Steril 2010; 95:970-972.
31. Pezeshki K, Feldman J, Stein DE, et al. Bleeding and spontaneous abortion after therapy for infertility. Fertil Steril 2000; 74:504-508.
32. Brandes M, Verzijden CJM, Hamilton CJCM, et al. Is the fertility treatment itself a risk factor for early pregnancy loss? Reprod Biomed Online 2011; 22:192-199.
33. The ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update 2009; 15:265-277.
34. Nuojua-Huttunen S, Tomas C, Bloigu R, et al. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999; 14:698-703.
35. Zadehmodarres S, Oladi B, Saeedi S, et al. Intrauterine insemination with husband semen: an evaluation of pregnancy rate and factors affecting outcome. J Assist Reprod Genet 2009; 26:7-11.
36. Tournaye H. Male factor infertility and ART. Asian J Androl 2012; 14:103-108.
37. Aboulghar M, Mansour R, Serour G, et al. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials. Fertil Steril 2001; 75:88-91.
38. Morshedi M, Duran HE, Taylor S, et al. Efficacy and pregnancy outcome for two methods of semen preparation for intrauterine insemination: a prospective randomized study. Fertil Steril 2003; 79 (Suppl. 3):1625-1632.
39. Belloc S, Cohen-Bacrie P, Benkhalifa M, et al. Effect of maternal age and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online 2008; 17:392-397.
40. Duran EH, Morshedi M, Taylor S, et al. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Hum Reprod 2002; 17:3122-3128.
41. Evanson DP, Larson KL, Jost LK. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl 2002; 23:25-43.
42. Gil-Villa AM, Cardona-Maya W, Agarwal A, et al. Assessment of sperm factors possibly involved in early recurrent pregnancy loss. Fertil Steril 2010; 94:1465-1472.
43. Vissenberg R, Goddijn M. Is there a role for assisted reproductive technology in recurrent miscarriage? Semin Reprod Med 2011; 29:548-554.
44. Puscheck EE, Jeyendran RS. The impact of male factor on recurrent pregnancy loss. Curr Opin Obstet Gynecol 2007; 19:172-176.
45. Cohen J, Mayaux MJ, Guihard-Moscato ML. Pregnancy outcomes after in vitro fertilization: a collaborative study on 2342 pregnancies. Ann NY Acad Sci 1988; 541:1-6.
46. FIVNAT. Pregnancies and birth resulting from in vitro fertilization: French national registry, analysis of data 1986 to 1990. Fertil Steril 1995; 1:746-756.
47. Ezra Y, Schenker JG. Abortion rate in assisted reproduction: true increase? Early Pregnancy 1995; 1:171-175.
48. Qin J, Pang L, Li M, et al. Risk of chromosomal abnormalities in early spontaneous abortion after assisted reproductive technology: a metaanalysis. PLoS One 2013; 8:e75953.
49. Pedina AA, Efimova OA, Chiryaeva OG, et al. A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years. J Assist Reprod Genet 2014; 31:149-155.
50. Bettio D, Venci A, Levi Setti PE. Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta 2008; 29 (Suppl. B):S126-S128.
51. Martinez MC, Mendez C, Ferro J, et al. Cytogenetic analysis of early nonviable pregnancies after assisted reproduction treatment. Fertil Steril 2010; 93:289-292.
52. Wong MYW, Ledger WL. Is ICSI risky? Obstet Gynecol Int 2013; 2013:473289. doi: 10.1155/2013/473289.
53. Davies M, Moore V, Willson K, et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012; 366:1803-1813.
54. Bingol B, Abike F, Gedikbasi A, et al. Comparison of chromosomal abnormality rates in ICSI for nonmale factor and spontaneous conception. J Assist Reprod Genet 2012; 29:25-30.
55. Bahceci M, Ulug U. Does underlying infertility aetiology impact on first trimester miscarriage rate following ICSI? A preliminary report from 1244 singleton gestations. Hum Reprod 2005; 20:717-721.
56. Wang JX, Norman RJ, Wilcox AJ. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technologies. Hum Reprod 2004; 19:272-277.
57. Winter E,Wang J,DaviesMJ, NormanR. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod 2002; 17:3220-3223.
58. ASRM/SART Registry. Assisted reproductive technology in the United States: 1999. Fertil Steril 2002; 78:918-931.